An integrated resource for biotech IPO readiness
An IPO is a pivotal milestone in the life of a biotech company, acting as an important catalyst to advance clinical development. The process is unique and intense, with precise requirements that must be met according to certain timelines.
Navigating these hurdles is demanding,particularly for companies with limited internal resources or management teams who are new to the experience.
We support and streamline the IPO readiness process. With >60 successful transactions under our belt, we provide expert guidance — from strategic CFO leadership to investor relations — ensuring you’re well prepared for the journey.
Why Danforth for Your IPO Readiness and Execution?
- Deep Knowledge and Experience: Pursue the path that’s best for you. We are experienced in both traditional and non-traditional routes to the US capital markets, including reverse mergers and SPAC transactions, as well as cross-border IPO transactions for prospective registrants in Europe and beyond.
- Critical Relationships: Seamless execution requires coordination across numerous players. We have extensive relationships with Big 4 auditors, SEC counsel and life science investment bankers, allowing for close collaboration throughout the IPO readiness process.
- End-to-End Support: We provide institutional continuity by managing pre-effective support and post-effective SEC compliance and operational accounting.
Ready to start planning for IPO readiness?
Schedule a conversation to find out how we can help.
How Danforth Can Help
Process Management
Smoothly navigate the IPO readiness process with our expert thought partnership, technical expertise, and broad support service network.
Buy and Sell Side Support
We manage the investment banking syndicate, support TTW communications, and prepare the roadshow – whether conducted virtually or in person.
Financial Planning and Analysis (FP&A)
We prepare budgets, long-range plans, and cost analyses which can support corporate planning, buy and sell side discussions and SEC disclosure.
Risk Mitigation
Our specialist team mitigates accounting and reporting risks with efficient execution. We can also advise on the accurate reporting of potential risk factors in your Form S-1.
Audit Preparation
We prepare for external PCAOB audits and SEC-compliant financial reporting, including disclosure “upgrades” for EPS calculations, pro-forma presentations, segmental reporting, going concern disclosures, related-party matters and taxation disclosures.
Public Readiness
Get tailored advice on corporate governance, risk management, insurance, policies and procedures and Sarbanes-Oxley compliance.
Form S-1 Financials
We can lead or supplement your team to prepare historical financials, and other financial elements of your S-1 registration statement.
Form S-1 Business Section
Our drafting specialists with extensive life science financing backgrounds help optimally showcase your company to investors.
Strategic Communications and Investor Relations
Drive lasting investor engagement with strategic communications that leverage engaging story and relationship-building.
Ready to strengthen your foundation for financial growth?
From strategic guidance to IPO readiness, Danforth Health delivers deep life science partnerships to guide you through every step of your journey.
Learn how our finance and operations specialists can take you further.
